基于超声造影特征预测肝细胞腺瘤与局灶性结节性增生概率的模型
本研究纳入324例超声造影检查(局灶性结节性增生181例、肝细胞腺瘤143例),分析肝细胞腺瘤与局灶性结节性增生的超声造影特征出现频率及其鉴别预测价值。两组在年龄及脂肪变、回声、均匀性、中央瘢痕、中央动脉、动脉期增强模式、坏死或血栓、晚静脉期增强等超声造影特征上存在显著差异。
要点
- 肝细胞腺瘤与局灶性结节性增生在年龄及多项超声造影特征上存在显著差异。
- 中央瘢痕、中央动脉、动脉期增强模式及晚静脉期增强是鉴别的关键超声造影特征。
- 脂肪变、回声、均匀性、坏死或血栓等特征在两组间也有显著差异。
核心结论
- 肝细胞腺瘤与局灶性结节性增生在年龄及脂肪变、回声、均匀性、中央瘢痕、中央动脉、动脉期增强模式、坏死或血栓、晚静脉期增强等超声造影特征上存在显著差异。
研究设计与样本
- 研究纳入324例超声造影检查,其中局灶性结节性增生181例、肝细胞腺瘤143例。
关键影像表现/征象
- 肝细胞腺瘤与局灶性结节性增生在脂肪变、回声、均匀性、中央瘢痕、中央动脉、动脉期增强模式、坏死或血栓、晚静脉期增强等超声造影特征上存在显著差异。
诊断标准与关键数值
- 原文报告肝细胞腺瘤与局灶性结节性增生在年龄及脂肪变、回声、均匀性、中央瘢痕、中央动脉、动脉期增强模式、坏死或血栓、晚静脉期增强等超声造影特征上存在显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Contrast-enhanced ultrasound (CEUS) is an emerging imaging technique that is increasingly used to diagnose liver lesions. It is of the utmost importance to differentiate between the two most common solid focal liver lesions (i.e., hepatocellular adenoma [HCA] and focal nodular hyperplasia [FNH]), because their management and follow-up differ greatly. The main objective of this study was to determine how frequently the specific CEUS features of HCA and FNH are visible on CEUS and to define their predictive value for discrimination between HCA and FNH. We included 324 CEUS examinations performed on patients with FNH (n = 181) or HCA (n = 143). Patients with HCA and FNH significantly differed with respect to age and CEUS features of steatosis, echogenicity, homogeneity, the presence of a central scar, central artery, arterial enhancement pattern, necrosis or thrombus and enhancement in the late venous phase.
引用
- Taimr P, Bröker MEE, Dwarkasing RS, et al. A Model-Based Prediction of the Probability of Hepatocellular Adenoma and Focal Nodular Hyperplasia Based on Characteristics on Contrast-Enhanced Ultrasound. Ultrasound Med Biol. 2017. PMID: 28743375. doi:10.1016/j.ultrasmedbio.2017.05.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。